Search results for:
midazolam
midazolam
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Versed |
SOLUTION, INJECTABLE |
1 mg/mL preservative-free, 5 mg/mL preservative-free |
|
|
|
|
| Versed |
SOLUTION, INJECTABLE |
1 mg/mL, 5 mg/mL |
|
|
|
|
| Nayzilam |
SPRAY, NASAL |
5 mg/0.1 mL per spray |
|
|
|
|
| Versed |
SYRUP, ORAL |
2 mg/mL |
|
|
|
|
Last updated: Sep. 23, 2025
Note: IV push midazolam is restricted to use in the ICUs or procedural areas. Midazolam infusions are restricted to the ICUs with the exception of palliative care/comfort care only/hospice patients. For any midazolam order deemed inappropriately active, call the provider to discontinue unless approved for automatic discontinuation as follows:
Pediatric Oral/Intranasal Midazolam Administration Guidelines
Updated: Dec 2020 (Nayzilam)